Sign Up Today and Learn More About Aurealis Therapeutics Stock
Invest in or calculate the value of your shares in Aurealis Therapeutics or other pre-IPO companies through EquityZen's platform.
Aurealis Therapeutics Stock
Aurealis Therapeutics is a swiss-finnish private biopharmaceutical company
About Aurealis Therapeutics Stock
Founded
2015
Industries
Aurealis Therapeutics Press Mentions
Stay in the know about the latest news on Aurealis Therapeutics
Aurealis Therapeutics on LinkedIn: #aurealistherapeutics #partneringweek #china #biotech #collaboration…
linkedin • Jun 25, 2024
Aurealis Therapeutics on LinkedIn: #dfu #diabeticfootulcers #clinicaltrials #patientrecruitment #biotech…
linkedin • May 23, 2024
Aurealis Therapeutics' lead candidate AUP-16 for chronic wounds receives PRIME status from EMA
wboy • Mar 03, 2024
Aurealis Therapeutics banks $10 million in an oversubscribed round
startupticker • Apr 05, 2023
Aurealis Therapeutics Management
Leadership team at Aurealis Therapeutics
CEO
Juha Yrjänheikki
Join now and verify your accreditation status to gain access to:
- Aurealis Therapeutics current valuation
- Aurealis Therapeutics stock price
- Available deals in Aurealis Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Aurealis Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Aurealis Therapeutics through EquityZen funds. These investments are made available by existing Aurealis Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aurealis Therapeutics stock?
Shareholders can sell their Aurealis Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
